StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by jjwilsonon May 15, 2020 10:49pm

154 Views

Post# 31037009

RE:RE:RE:RE:Interesting filing on sedar tonight

Nailbiter1;

Your link is dead and when I try to get into SEDAR I get an error message - don't know why because I was just there 10 minutes ago.

I'm assuming these are lines 9, 10, 11;

No attendees to participate.
Yes to proxy material being delivered.
Yes to SZLS paying to send proxy material.

Isn't that just what most companies have been doing during the Covid crisis - no attendees? I'm not sure what you're referring to as being significant.

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload